Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
Gastroenterology. 2019 Jun 03;:
Authors: Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, Cohen S, Peleg S, Shamali H, On A, Millman P, Abramas L, Ziv-Baran T, Grant S, Abitbol G, Dunn KA, Bielawski JP, Van Limbergen J
BACKGROUND & AIMS: Exclusive enteral nutrition (EEN) is recommended for children with mild-to-moderate Crohn’s disease (CD) but implementation is challenging. We compared EEN to the CD exclusion-diet (CDED), a whole-food diet coupled with partial enteral nutrition (PEN), designed to reduce exposure to dietary components that have adverse effects on the microbiome and intestinal barrier.
METHODS: We performed a 12-week prospective trial of children with mild to moderate CD. The children were randomly assigned to a group that received CDED plus 50% of calories from formula (Modulen, Nestlé) for 6 weeks (stage 1) followed by CDED with 25% PEN from weeks 7-12 (stage-2) (n=40, group 1) or a group that received EEN for 6 weeks followed by a free diet with 25% PEN from weeks 7-12 (n=38, group 2). Patients were evaluated at baseline and weeks 3, 6, and 12 and laboratory tests were performed. 16S rRNA gene (V4V5) sequencing was performed on stool samples. The primary endpoint was dietary tolerance. Secondary endpoints were intention to treat (ITT) remission at week 6 ( pediatric CD activity index score below 10) and corticosteroid-free ITT sustained remission at week 12.
RESULTS: Four patients withdrew from the study because of intolerance by 48 hours, 74 patients (mean age 14.2±2.7 years) were included for remission analysis. The combination of CDED and PEN was tolerated in 39 children (97.5%), whereas EEN was tolerated by 28 children (73.6%) (P=.002; odds ratio for tolerance of CDED and PEN, 13.92; 95% CI, 1.68-115.14). At week 6, 30/40 children (75%) given CDED plus PEN were in corticosteroid-free remission vs 20/34 children (59%) given EEN (P=.38). At week 12, 28/37 children (75.6%) given CDED plus PEN were in corticosteroid-free remission compared with 14/31 children (45.1%) given EEN and then PEN (P=.01; odds ratio for remission in children given CDED and PEN, 3.77; CI, 1.34-10.59). In children given CDED plus PEN, corticosteroid-free remission was associated with sustained reductions in inflammation (based on serum level of C-reactive protein and fecal level of calprotectin) and fecal Proteobacteria.
CONCLUSION: CDED plus PEN was better tolerated than EEN in children with mild to moderate CD. Both diets were effective in inducing remission by week 6. The combination CDED plus PEN induced sustained remission in a significantly higher proportion of patients than EEN, and produced changes in the fecal microbiome associated with remission. These data support use of CDED plus PEN to induce remission in children with CD. Clinicaltrials.gov no: NCT01728870.
PMID: 31170412 [PubMed – as supplied by publisher]